secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001654954-23-001757
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin reports Q2 FY2023 net loss $1.4M, Vyleesi net revenue up 18% QoQ
------------------------------------------------------------------------

- Net loss of $1.4M ($0.13/share) improved from $8.7M loss ($0.91) YoY; includes $4.7M tax benefit.
- Vyleesi net product revenue $1.0M, up 18% vs prior quarter; prescriptions dispensed up 12%.
- PL9643 Phase 3 dry eye trial enrollment on track; topline data expected mid-2023.
- PL8177 Phase 2 UC trial commenced; interim analysis H1 2023, topline H2 2023.
- Cash $21.2M plus $6.5M receivables; sufficient through calendar 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495423001757/0001654954-23-001757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495423001757/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-001757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer